Vanguard Group’s Chinook Therapeutics, Inc. Common Stock KDNY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
|
|||||
|
2023
Q2 | $113M | Buy |
|
|||||
|
2023
Q1 | $65.9M | Buy |
|
|||||
|
2022
Q4 | $73.2M | Buy |
|
|||||
|
2022
Q3 | $47.2M | Buy |
|
|||||
|
2022
Q2 | $41.3M | Buy |
|
|||||
|
2022
Q1 | $29.9M | Buy |
|
|||||
|
2021
Q4 | $29.1M | Buy |
|
|||||
|
2021
Q3 | $18.3M | Buy |
|
|||||
|
2021
Q2 | $19.6M | Buy |
|
|||||
|
2021
Q1 | $18.7M | Buy |
|
|||||
|
2020
Q4 | $18.7M | Buy |
|
|||||
|
2020
Q3 | $7.76M | Buy |
|
|||||
|
2020
Q2 | $5.92M | Buy |
|
|||||
|
2020
Q1 | $6.52M | Buy |
|
|||||
|
2019
Q4 | $2.46M | Sell |
|
|||||
|
2019
Q3 | $2.36M | Sell |
|
|||||
|
2019
Q2 | $3.88M | Buy |
|
|||||
|
2019
Q1 | $9.8M | Sell |
|
|||||
|
2018
Q4 | $8.63M | Sell |
|
|||||
|
2018
Q3 | $29.6M | Buy |
|
|||||
|
2018
Q2 | $25.7M | Buy |
|
|||||
|
2018
Q1 | $32.4M | Buy |
|
|||||
|
2017
Q4 | $25.9M | Buy |
|
|||||
|
2017
Q3 | $29.5M | Buy |
|
|||||
|
2017
Q2 | $28.6M | Buy |
|
|||||
|
2017
Q1 | $25.6M | Buy |
|
|||||
|
2016
Q4 | $26.6M | Buy |
|
|||||
|
2016
Q3 | $27.3M | Buy |
|
|||||
|
2016
Q2 | $20.3M | Buy |
|
|||||
|
2016
Q1 | $19.9M | Buy |
|
|||||
|
2015
Q4 | $42.3M | Buy |
|
|||||
|
2015
Q3 | $2.32M | Buy |
|
|||||
|
2015
Q2 | $1.3M | Buy |
|